The African Street Journal Zambia
About

Zambia launches three-month injectable contraceptive

The Subcutaneous Medogen injection contains 104 milligrams of Medroxyprogesterone Acetate and is intended to widen access to family planning.

Zambia’s government has launched Subcutaneous Medogen, an injectable contraceptive for women that provides three months of pregnancy protection. The product is intended to expand access to affordable, quality-assured family planning services.

The injection is administered under the skin and contains 104 milligrams of Medroxyprogesterone Acetate. Health Minister Professor Roma Chilengi spoke at the launch, according to Lusaka Times.

The launch introduces the product as a new option in Zambia’s family planning services. The report gave no further details about its availability or price.

Why it mattersWomen seeking contraception have a newly launched option that provides three months of pregnancy protection.